Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

 Dow Down 0.20% Nasdaq Up 0.02%
Celldex Therapeutics, Inc. (CLDX)At 4:00PM EDT: 5.14  Up 0.01 (0.19%)  
More on CLDX
Quotes
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
HereIncome Statement

Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2010Dec 31, 2009Sep 30, 2009Jun 30, 2009
Total Revenue 3,713   4,733   4,030   2,685  
Cost of Revenue -   -   -   -  
Gross Profit 3,713   4,733   4,030   2,685  
Operating Expenses
Research Development6,438  2,440  7,241  10,032  
Selling General and Administrative2,835  6,418  3,850  3,510  
Non Recurring2,327  8,397  604  (2,834)
Others1,520  663  95  96  
Total Operating Expenses13,120  17,918  11,790  10,804  
Operating Income or Loss (9,407) (13,185) (7,156) (8,723)
Income from Continuing Operations
Total Other Income/Expenses Net3,162  165  586  (626)
Earnings Before Interest And Taxes(6,245)(13,624)(6,570)(9,349)
Interest Expense337  452   -  (40)
Income Before Tax(6,582)(14,076)(6,570)(9,309)
Income Tax Expense -  (529) -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(6,582)(13,547)(6,570)(9,309)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (6,582) (12,943) (7,174) (8,705)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares ($6,582) ($12,943) ($7,174) ($8,705)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More